These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11880205)

  • 1. Natural killer T (NKT) cells and their role in antitumor immunity.
    Brutkiewicz RR; Sriram V
    Crit Rev Oncol Hematol; 2002 Mar; 41(3):287-98. PubMed ID: 11880205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of natural killer T cells in antitumor immunotherapy.
    Hong C; Park SH
    Crit Rev Immunol; 2007; 27(6):511-25. PubMed ID: 18197797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of immune responses by CD1d-restricted natural killer T cells.
    Van Kaer L
    Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
    van der Vliet HJ; Molling JW; von Blomberg BM; Nishi N; Kölgen W; van den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ
    Clin Immunol; 2004 Jul; 112(1):8-23. PubMed ID: 15207777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Going both ways: immune regulation via CD1d-dependent NKT cells.
    Godfrey DI; Kronenberg M
    J Clin Invest; 2004 Nov; 114(10):1379-88. PubMed ID: 15545985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of antitumour immunity by CD1d-restricted NKT cells.
    Swann J; Crowe NY; Hayakawa Y; Godfrey DI; Smyth MJ
    Immunol Cell Biol; 2004 Jun; 82(3):323-31. PubMed ID: 15186264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer T cell-mediated antitumor immune responses and their clinical applications.
    Seino K; Motohashi S; Fujisawa T; Nakayama T; Taniguchi M
    Cancer Sci; 2006 Sep; 97(9):807-12. PubMed ID: 16805854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
    Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
    J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical cord blood NK T cells kill tumors by multiple cytotoxic mechanisms.
    Gansuvd B; Hagihara M; Yu Y; Inoue H; Ueda Y; Tsuchiya T; Masui A; Ando K; Nakamura Y; Munkhtuvshin N; Kato S; Thomas JM; Hotta T
    Hum Immunol; 2002 Mar; 63(3):164-75. PubMed ID: 11872234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
    Cardell SL
    Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.
    Gumperz JE; Miyake S; Yamamura T; Brenner MB
    J Exp Med; 2002 Mar; 195(5):625-36. PubMed ID: 11877485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular immune privilege and CD1d-reactive natural killer T cells.
    Sonoda KH; Stein-Streilein J
    Cornea; 2002 Mar; 21(2 Suppl 1):S33-8. PubMed ID: 11995808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
    Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
    J Exp Med; 2003 Apr; 197(8):1051-7. PubMed ID: 12695492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD1d-mediated antigen presentation to natural killer T (NKT) cells.
    Brutkiewicz RR; Lin Y; Cho S; Hwang YK; Sriram V; Roberts TJ
    Crit Rev Immunol; 2003; 23(5-6):403-19. PubMed ID: 15030309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of immune privilege for tumor cells by regulatory cytokines produced by innate and acquired immune cells.
    Seo N; Hayakawa S; Tokura Y
    Semin Cancer Biol; 2002 Aug; 12(4):291-300. PubMed ID: 12147203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD1d-restricted NKT cells contribute to the age-associated decline of T cell immunity.
    Faunce DE; Palmer JL; Paskowicz KK; Witte PL; Kovacs EJ
    J Immunol; 2005 Sep; 175(5):3102-9. PubMed ID: 16116199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.